Quinoline antimalarials: Mechanisms of action and resistance

International Journal for Parasitology

Volumn 27, Issue 2, 1997, Pages 231-240

  Foley, Mick ^a   Tilley, Leann ^a  

^a LA TROBE UNIVERSITY   (Australia)

Author keywords

chloroquine; drug resistance; haem polymerisation; malaria; mefloquine; P glycoprotein; photoaffinity labelling; quinoline antimalarials

Indexed keywords

CHLOROQUINE; HEME; MEFLOQUINE; QUINOLINE DERIVATIVE;

CONFERENCE PAPER; DRUG MECHANISM; DRUG RESISTANCE; HUMAN; MALARIA; MOLECULAR BIOLOGY; NONHUMAN; POLYMERIZATION;

ANIMALS; ANTIMALARIALS; BLOOD PROTEINS; CHLOROQUINE; DRUG RESISTANCE; ERYTHROCYTES; HEMOGLOBINS; HUMANS; MEFLOQUINE; MEMBRANE PROTEINS; PLASMODIUM; QUININE; QUINOLINES;

CINCHONA PUBESCENS;

EID: 0031080653     PISSN: 00207519     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0020-7519(96)00152-X     Document Type: Conference Paper

References (60)

1. Barnes D. A., Foot S. J., Galatis D., Kemp D. J. & Cowman A. F. 1992. Selection for high-level chloroquine resistance results in deamplification of the pfmdr1 gene and increased sensitivity to mefloquine in Plasmodium falciparum. The European Molecular Biology Organisation Journal 11: 3067-3075.
2. Bayley H. & Knowles J. R. 1977. Photoaffinity labelling. Methods in Enzymology 46: 69-114.
3. Berman A., Shearing L. N., Ng K. F., Jinsart W. & Foley M., Tilley L. 1994. Photoaffinity labelling of Plasmodium falciparum proteins involved in phospholipid transport. Molecular and Biochemical Parasitology 67: 235-243.
4. Brasseur P., Druilhe P., Kouamouo O., Brandicourt O., Danis M. & Moyou S. R. 1986. High level of sensitivity to chloroquine of 72 Plasmodium falciparum isolates from Southern Cameroon in January 1985. American Journal of Tropical Medicine and Hygiene 35: 711-716.
5. Bzik D. J. & Fox B. A., Gonyer K. 1993. Expression of Plasmodium falciparum lactate dehydrogenase in Escherichia coli. Molecular and Biochemical Parasitology 59: 155-166.
6. Chen L. 1991. Recent studies on antimalarial efficacy of piperaquine and hydroxypiperaquine. Chinese Medical Journal 104: 161-163.
7. Chou A. C. & Fitch C. D. 1993. Control of heme polymerase by chloroquine and other quinoline derivatives. Biochemical and Biophysical Research Communications 195: 422-428.
8. Cordon-Cardo C., O'Brien J. P., Casals D., Rittman-Grauer L., Biedler J. L., Melamed M. R. & Bertino J. R. 1989. Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proceedings of the National Academy of Science U.S.A. 86: 695-698.
9. Cowman A. F., Galatis D. & Thompson J. K. 1994. Selection for mefloquine resistance in Plasmodium falciparum is linked to amplification of the pfmdr1 gene and cross-resistance to halofantrine and quinine. Proceedings of the National Academy of Science U.S.A. 91: 1143-1147.
10. Desneves J., Thorn G., Berman A., Galatis D., La Greca N., Sinding J., Foley M., Deady L. W., Cowman A. F. & Tilley L. 1996. Photoaffinity labelling of mefloquine-binding proteins in human serum, uninfected erythrocytes and Plasmodium falciparum-infected erythrocytes. Molecular and Biochemical Parasitology 82: 181-194.
11. Dorn A., Stoffel R., Matile H., Bubendorf A., Ridley R. G. 1995. Malarial haemozoin/ β-haematin supports haem polymerisation in the absence of protein. Nature 374: 269-271.
12. Egan T. J., Ross D. C. & Adams P. A. 1994. Quinoline antimalarial drugs inhibit spontaneous formation of β-haematin (malaria pigment). Federation of European Biochemical Society Letters 352: 54-57.
13. Elslager E. F., Tendick F. H., Werbel L. M. 1969. Repository drugs. VIII. Ester and amide congeners of amodiaquine, hydroxychloroquine, oxychloroquine, primaquine, quinacrine and related substances as potential long-acting antimalarial agents. Journal of Medicinal Chemistry 12: 600-607.
14. Fitch C. D., Chan R. L. & Chevli R. 1979. Chloroquine resistance in malaria: accessibility of drug receptors to mefloquine. Antimicrobial Agents and Chemotherapy 15: 258-262.
15. Fitch C. D., Yunis N. G., Chevli R. & Gonzales Y. 1974. High-affinity accumulation of chloroquine by mouse erythrocytes infected with Plasmodium berghii. Journal of Clinical Investigation 54: 24-33.
16. Foote S. J. & Cowman A. F. 1994. The mode of action and mechanism of resistance to antimalarial drugs. Acta Tropica 56: 157-171.
17. Foote S. J., Kyle D. E., Martin R. K., Oduola A. M. J., Forsyth K., Kemp D. J. & Cowman A. F. 1990. Several alleles of the multidrug-resistance gene are closely linked to chloroquine resistance in Plasmodium falciparum. Nature 345: 255-258.
18. Foley M., Deady L. W., Ng K., Cowman A. F. & Tilley L. 1994. Photoaffinity labelling of chloroquine-binding proteins in Plasmodium falciparum. Journal of Biological Chemistry 269: 6955-6961.
19. Gay F., Bustos D. G., Diquet B., Rivero L. R., Litaudon M., Pichet C., Danis M. & Gentilini M. 1992. Cross-resistance between mefloquine and halofantrine. The Lancet 336: 1262.
20. Geary T. G. & Jensen J. B. 1983. Lack of cross-resistance to 4-aminoquinolines in chloroqqine-resistant Plasmodium falciparum in vitro. Journal of Parasitology 69: 97-105.
21. Geary T. G., Bonanni L. C., Jensen J. B. & Ginsburg H. 1986. Effects of combinations of quinoline-containing antimalarials on Plasmodium falciparum in culture. Annals of Tropical Medicine and Parasitology 80: 285-291.
22. Ginsburg H., Nissani E. & Krugliak M. 1989. Alkalinisation of the food vacuole of malaria parasites by quinoline drugs and alkylamines is not correlated with their antimalarial activity. Biochemical Pharmacology 38: 2645-2654.
23. Goldberg D. E., Slater A. F. G., Cerami A. & Henderson G. B. 1990. Hemoglobin degradation in the malaria parasite Plasmodium falciparum: an ordered process in a unique organelle. Proceedings of the National Academy of Science U.S.A. 87: 2931-2935.
24. Grellier P., Rigomier D., Clavey V., Fruchart J.-C. & Schrevel J. 1991. Lipid traffic between high density lipoproteins and Plasmodium falciparum-infected red blood cells. Journal of Cell Biology 112: 267-277.
25. Hennequin C., Bourée P., Bazin N. & Bisaro F., Feline A. 1994. Severe psychiatric side effects observed during prophylaxis and treatment with mefloquine. Archives of Internal Medicine 154: 2360-2362.
26. Hiebl-Dirschmied C. M., Entler B., Glotzmann C., Maurer-Fogy I., Stratowa C. & Prohaska R. 1991. Cloning and nucleotide sequence of cDNA encoding human erythrocyte band 7 integral membrane protein. Biochimica et Biophysica Acta 1090: 123-124.
27. Krogstad D. J., Schlesinger P. H. & Gluzman I. Y. 1985. Antimalarials increase vesicle pH in Plasmodium falciparum. Journal of Cellular Biology 101: 2301-2309.
28. Kyle D. E., Milhous W. K. & Rossan R. N. 1993. Reversal of Plasmodium falciparum resistance to chloroquine in Panamanian Aotus monkeys. American Journal of Tropical Medicine and Hygiene 48: 126-133.
29. Le Bras J., Deloron P., Ricour A., Andrieu B., Savel J. & Couland J. P. 1983. Plasmodium falciparum: drug sensitivity in vitro of isolates before and after adaptation to continuous culture. Experimental Parasitology 56: 9-14.
30. Loeb R. F., Clarke W. M., Coateney G. R., Coggeshall L. T., Dieuaide F. R., Dochez A. R., Hakansson E. G., Marshall E. K., Marvel S. C., McCoy O. R., Sapero J. J., Serbell W. H., Shannon J. A. & Garden G. A. 1946. Activity of a new antimalarial agent, chloroquine (SN 7618). Journal of the American Medical Association 130: 1069-1070.
31. Looareesuwan S., Viravan C., Vanijanonta S., Wilairatana P., Suntharasamai P., Charoenlarp P., Arnold K., Kyle D., Canfield C. & Webster K. 1992. Randomised trial of artesunate and mefloquine alone and in sequence for acute uncomplicated falciparum malaria. The Lancet 339: 821-824.
32. Martin S. K., Oduola A. M. J. & Milhous W. K. 1987. Reversal of chloroquine resistance in Plasmodium falciparum by verapamil. Science 235: 899-901.
33. Mu J. Y., Israili Z. H. & Dayton P. G. 1975. Studies of the disposition and metabolism of mefloquine HC1 (WR 142, 490), a quinolinemethanol antimalarial, in the rat. Drug Metabolism and Disposition 3: 198-210.
34. Oduola A. M. J., Omitowoju G. O., Gerena L., Kyle D. E., Milhous W. K., Sowunmi A. & Salako L. A. 1992. Reversal of mefloquine resistance with penfluridol in isolates of Plasmodium falciparum from south-west Nigeria. Transactions of the Royal Society of Tropical Medicine and Hygiene 87: 81-83.
35. Ohsawa K., Tanabe K. & Kimata I., Miki A. 1991. Ultrastructural changes associated with reversal of chloroquine resistance by verapamil in Plasmodium chabaudi. Parasitology 103: 185-189.
36. Orjih A. U., Banyal H. S., Chelvi R. & Fitch C. D. 1981. Hemin lyses malarial parasites. Science 214: 667-669.
37. Peters W. 1970. Chemotherapy and Drug Resistance in Malaria. Academic Press, London.
38. Raynes K., Galatis D., Cowman A. F., Tilley L. & Deady L. W. 1995. Synthesis and activity of some antimalarial bisquinolines. Journal of Medicinal Chemistry 38: 204-206.
39. Raynes K., Foley M. & Tilley L. Novel bisquinoline antimalarials. Biochemical Pharmacology 52: 551-559.
40. Rifften C. D., Chung R., Wall D. M., Zalcberg J. R., Cowman A. F., Foley M. & Tilley L. 1996. Modulation of the function of human MDR1 P-glycoprotein by the antimalarial drug mefloquine. Biochemical Pharmacology 52: 1545-1552.
41. Riordan J. R., Deuchars K., Kartner N., Alon N. & Trent J., Ling V. 1985. Amplification of P-glycoprotein genes in multidrug-resistant mammalian cell lines. Nature 316: 817-819.
42. Safa A. R. 1988. Photoaffinity labelling of the multidrug-resistant mammalian cell lines. Proceedings of the National Academy of Science U.S.A. 85: 7187-7191.
43. San George R. C., Nagel R. L. & Farby M. E. 1984. On the mechanism of the red-cell accumulation of mefloquine, an antimalarial drug. Biochimica et Biophysica Acta 803: 174-181.
44. Schmidt L. H., Crosby R. & Rasco J., Vaughan D. 1978. Antimalarial activities of various 4-quinolinemethanols with special attention to WR-142,490 (mefloquine). Antimicrobial Agents and Chemotherapy 13: 1011-1030.
45. Schwartz D. E., Eckert G., Hartmann D., Weber B., Richard-Lenoble D., Ekue J. M. K. & Gentilini M. 1982. Single dose kinetics of mefloquine in man. Chemotherapy 28: 70-84.
46. Slater A. 1993. Chloroquine: mechanism of drug action and resistance in Plasmodium falciparum. Pharmaceutical Therapy 57: 203-235.
47. Slater A. F. G. & Cerami A. 1992. Inhibition by chloroquine of a novel haem polymerase enzyme activity in malaria trophozoites. Nature 355: 167-169.
48. Slater A. F. G., Swiggard W. J., Orton B. R., Flitter W. D., Goldberg D. E., Cerami A. & Henderson G. B. 1991. An iron-carboxylate bond links the heme units of malarial parasite pigment. Proceedings of the National Academy of Science U.S.A. 88: 325-329.
49. Somasundaram B., Norman J. C. & Mahaut-Smith M. P. 1995. Primaquine, an inhibitor of vesicular transport, blocks the calcium-release-activated current in rat megakaryocytes. Biochemical Journal 309: 725-729.
50. van Es H. H. G., Karcz S., Chu F., Cowman A. F., Vidal S. & Gros P., Schurr E. 1994. Expression of the plasmodial pfmdr1 gene in mammalian cells is associated with increased susceptibility to chloroquine. Molecular and Cellular Biology 14: 2419-2428.
51. Vander Jagt D. L., Hunsaker L. A. & Campos N. M. 1986. Characterisation of a hemoglobin-degrading, low molecular weight protease from Plasmodium falciparum. Molecular and Biochemical Parasitology 18: 389-400.
52. Vanderkooi G., Prapunwattana P. & Yuthavong Y. 1988. Evidence for electrogenic accumulation of mefloquine by malarial parasites. Biochemical Pharmacology 37: 3623-3631.
53. Vennerstrom J. L., Ellis W. Y., Ager A. L., Andersen S. L., Gerena L. & Milhous W. K. 1992. Bisquinolines: N,N-bis(7-chloroquinolin-4-yl)alkanediamines with potential against chloroquine-resistant malaria. Journal of Medicinal Chemistry 35: 2129-2134.
54. Watt G., Loesuttivibool L., Shanks G. D., Bordreau E. F., Brown A. E., Pavanand K., Webster H. K. & Wechgritaya S. 1992. Quinine with tetracycline for the treatment of drug-resistant falciparum malaria in Thailand. American Journal of Tropical Medicine and Hygiene 47: 108-111.
55. Wellems T. E., Walker-Jonah A. & Panton L. J. 1991. Genetic mapping of the chloroquine-resistance locus on Plasmodium falciparum chromosome 7. Proceedings of the National Academy of Science U.S.A. 88: 3382-3386.
56. Wellems T. E., Panton L. J., Gluzman I. Y., Rosario V. E., Gwadz R. W., Walker-Jonah A. & Krogstad D. J. 1990. Chloroquine resistance is not linked to mdr-like genes in a Plasmodium falciparum cross. Nature 345: 253-255.
57. White N. J. 1994. Mefloquine in the prophylaxis and treatment of falciparum malaria. British Medical Journal 308: 286-287.
58. Wilson C. M., Serrano A. E., Wasley A., Bogenschutz M. P., Shankar A. H. & Wirth D. F. 1989. Amplification of a gene related to mammalian mdr genes in drug-resistant Plasmodium falciparum. Science 244: 1184-1186.
59. Wilson C. M., Volkman S. K., Thaithong S., Martin R. K., Kyle D. E., Milhous W. K. & Wirth D. F. 1993. Amplification of pfmdr1 associated with mefloquine and halofantrine resistance in P. falciparum from Thailand. Molecular and Biochemical Parasitology 57: 151-160.
60. Yayon A., Cabantchik Z. I. & Ginsberg H. 1984. Identification of the acidic compartment of Plasmodium falciparum-infected human erythrocytes as the target of the antimalarial drug chloroquine. The European Molecular Biology Organisation Journal 3: 2695-2700.